QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.108.024695v1 37/4/719    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pondugula, S. R. Articles by Chen, T. Search for Related Content PubMed PubMed Citation Articles by Pondugula, S. R. Articles by Chen, T.

A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor

Departments of Chemical Biology and Therapeutics (S.R.P., J.W., T.C.) and Pharmaceutical Sciences (C.B.-C., E.G.S.), St. Jude Children's Research Hospital, Memphis, Tennessee; and Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India (R.K.T.)

The pregnane X receptor (PXR) plays crucial roles in multiple physiological processes. However, the signaling mechanisms responsible are not well defined; it is most likely that multiple functions of PXR are modulated by its phosphorylation. Therefore, we sought to determine whether mutation at a highly conserved Thr⁵⁷ affects human PXR (hPXR) function. Site-directed mutagenesis was performed to generate phosphorylation-deficient (hPXR^T57A) and phosphomimetic (hPXR^T57D) mutants. Gene reporter, Western blotting, immunocytochemistry, mammalian two-hybrid, and electrophoretic mobility shift assays were used to study cytochrome P450 3A4 (CYP3A4) promoter activation, protein levels, localization, cofactor interaction, and CYP3A4 promoter binding of the hPXR mutants, respectively. hPXR^T57D, but not hPXR^T57A, lost its transcriptional activity. Neither mutation altered hPXR's protein levels and interaction with steroid receptor coactivator-1. hPXR and hPXR^T57A exhibited a homogenous nuclear distribution, whereas hPXR^T57D exhibited a distinctive punctate nuclear localization pattern similar to that of hPXR mutants with impaired function that colocalize with silencing mediator of retinoid and thyroid receptors (SMRT), although silencing of SMRT did not rescue the altered function of hPXR^T57D. However, hPXR^T57D, but not hPXR^T57A, impaired hPXR's ability to bind to the CYP3A4 promoter, consistent with the mutant's transactivation function. Furthermore, the 70-kDa form of ribosomal protein S6 kinase (p70 S6K) phosphorylated hPXR in vitro and inhibited its transcriptional activity, whereas hPXR^T57A partially resisted the inhibitory effect of p70 S6K. Our studies identify a functionally significant phosphomimetic mutant (hPXR^T57D) and show p70 S6K phosphorylation and regulation of hPXR transactivation to support the notion that phosphorylation plays important roles in regulating hPXR function.

This article has been cited by other articles:

				K. Lichti-Kaiser, D. Brobst, C. Xu, and J. L. Staudinger A Systematic Analysis of Predicted Phosphorylation Sites within the Human Pregnane X Receptor Protein J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 65 - 76. [Abstract] [Full Text] [PDF]